2nd world summit on Nanotechnology and Nanomedicine Research

  • clyto access

    Nanotechnology & Nanomedicine Conference [Series -2 ]

    February 15- 16, 2018 at St Hugh's College, University of Oxford, UK

Meet the expert advisors and Keynote Speakers

Professor Alexander Seifalian

The London BioScience Innovation Centre, London, United Kingdom

Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a year at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awards’ Winner of Most Innovative New Product 2012 for the “synthetic trachea”. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement,include BBC, ITV, WSJ, CNN, and many more.Currently he is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology.

Read more >

Professor Éva Valsami-Jones

University of Birmingham, United Kingdom

Eugenia (Éva) Valsami-Jones is a Professor of Environmental Nanoscience in the School of Geography, Earth & Environmental Sciences at the University of Birmingham, UK, where she also acts as Head of Research and Director of the NERC funded analytical facility FENAC. Éva holds a degree in Earth Sciences from the University of Athens and a PhD in Geochemistry from the University of Newcastle. Her current research focuses around (nano) particle reactivity and potential toxicity as well as the development of methodologies to identify and characterize nanoscale materials. She has pioneered stable-isotope labeled nanoparticles

Read more >

Clyto Access is pleased welcome to the 2nd International Conference on Nanotechnology and Nanomedicine (Nanomed 2018) 15 - 16 February, 2018 in St Hugh's College, University of Oxford, UK with the theme of exploring advancements in the field of Nanotechnology and Nanomedicine.

The aim of Nanomed 2018 is to bring together leading experts from academia and industry worldwide, to discuss the latest developments in the fields of Nanoscience & Nanotechnology. It also provides an interdisciplinary platform to establish business or research relations for future collaboration

The conference will feature world renowned keynote speakers, young research forum, poster presentations, workshops and scientific sessions to share the most recently breaking research development, discovery from different disciplines in Nanotechnology and Nanomedicine.

Points to discuss

☛ Nanotechnology for medical diagnosis
☛ Nanotechnology for renewable energy
☛ Nanotechnology for Drug delivery to treat chronic disorders
☛ Advanced nanotechnology for drug manufacturing and drug discovery


Related Topics

Nanodevices, Nanomedicine, Biomedical Engineering, Nanoscience Nanophotonics and Optics, MEMS, Nanodevices and Nanosensors, Nanostructures, Nanoelectronics, Polymer Technology, Nanosafety, Nanotoxicity, Nanocomposites, Nano-Catalysts, Nanoparticles synthesis, Nanomaterials Processing, Nanometrology, Nanoelectronics, Phontonics, Nanobiotechnology, Nanoelectronics, Nanofabrication and Characterisation, , Nanophotonics, , Nanofabrication, Nanocomposites and Multifunctional Materials.
Abstract submission deadline (1st round)
16 October 2017
Notification of acceptance or rejection of abstract
03-10 working days from the date of submission
Final presentation should be submitted
15 days before the conference date
Early bird registration
26 October 2017


☛ Synthesis and Advanced Characterization of Nanocomposites and Bio-inspired Materials
☛ Use of supramolecular chemistry to prepare nanostructures and nanomaterialsuse of supramolecular chemistry
☛ Nano-structured Materials for Drug Targeting, Release and Imaging
☛ Nanotechnology and green energy
☛ DNA Nanotechnology
☛ Nano Robots, Nano Devices & Nano Sensors
☛ Nano-biotechnology & Nanomedicine
☛ Nanoproteomics & Nanogenomics
☛ Nano-toxicology
☛ Nanoscience to mitigate pollution
☛ Insulin production and delivery through Nanomedicine
☛ Generation of nanoemulsions and nanosuspensions in pharmaceutical preparations
☛ Infrared Light-Activated Nanoconstructs in Biomedical Applications
☛ Translational Nano-Medicine: Targeted Therapeutic Delivery for Cancer, Pain, and Inflammatory Diseases
☛ Experimental Biophotonics
☛ Fabrication and Characterisation of Nanostructures
☛ Sensing and microanalytical devices with a particular focus on human and animal health
☛ Biomedical Materials and Regenerative Medicine
☛ Use of lipid nanoparticle (LNP) systems to deliver conventional and genetic drugs
☛ Mechanisms of cell-nanomaterial interactions
☛ Nanomaterials for tissue engineering and immunology
☛ Synthesis and characterisation of polymers and their evaluation in a variety of applications like drug delivery, gene delivery, photothermal therapy
☛ Development of micro and nanofluidic devices for analytical and bio-analytical applications and ultra-high sensitivity optical detection techniques
☛ Podocyte-targeted Therapeutic Nanodelivery to treat Proteinuric Glomerular Diseases
☛ Mathematical Modelling of Nanoscale Therapeutic Systems
☛ Fluorine-functionalized theranostics in anti-cancer treatment

What is Nanomed 2018?

Nanomedicine is an offshoot of nanotechnology and refers to highly-specific medical intervention at the molecular scale for curing diseases or repairing damaged tissues. Nanomedicine uses nano-sized tools for the diagnosis, prevention and treatment of disease and to gain increased understanding of the complex underlying pathophysiology of the disease.

Target Audience

• Dean, Department heads, Professors, Associate Professors, Assistant Professors, PhD Scholars, Graduates, Post Graduates, Junior/Senior Research Fellows and Scientists with a background in nanotechnology, polymer Science, pharmacology, physics, chemistry, biophysics, medicine, materials science and engineering.
• Nanotechnologists, Materials Scientists, Physicists, Chemists, Materials Engineers
• Directors, CEO’s of Chemical/ Materials/ Nano tech companies
• Members of different Nanotechnology, Materials Science, Physics, Nanomedicine, Pharmaceutical Nanotechnology associations and Societies
• R&D Researchers from Nanomedicine and Nanotechnology and engineering Industries
• Manufacturing Robots and Devices Companies

Why to attend Nanomed 2018 ?

• Acquire knowledge about current and trending technologies in the field of Nanomedicine and Nanotechnology engineering.
• Listen to best-renowned speakers via Keynote presentations, giving delegates the opportunity to hear the latest research or innovation in Nanomedicine.
• Network and share innovative ideas and research results on all aspects of Nanotechnology and Nanomedicine and indulge in interactive discussions and special sessions at the conference.
• Best opportunity to reach the an assemblage of participants from all over the world.
• Explore new research and latest developments in the Nanotechnology field and provide information on new techniques and technologies.


Nanotechnology involves the miniaturization of larger structures and chemicals at nanometric scale which has significantly revolutionized drug administration, thus influencing adoption of the technology through to 2025. The global nanotechnology market is poised to grow at a CAGR of around 18.1% over the next decade to reach approximately $173.95 billion by 2025 and nanomedicine market is estimated to witness a CAGR of 17.1% during the forecast period 2017–2023. The nanomedicine market is analyzed based on two segments – therapeutic applications and regions. The major drivers of the nanomedicine market include its application in various therapeutic areas, increasing R&D studies about nanorobots in this segment, and significant investments in clinical trials by the government as well as private sector. The Oncology segment is the major therapeutic area for nanomedicine application, which comprised more than 35% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the nanomedicine market in the future.


The Panel discussions will provide an opportunity to discuss research challenges and recent advancements in the field of nanotechnology and nanomedicine.
Presentations includes keynote talk, Speaker presentations, poster presentations. The best young researcher award and best poster award will be awarded for the presentations.
Meetings include editorial board meetings, and round table meetings which will provide more scope to enlighten your research with eminent speakers from all over the world.
Programs Programs Detail Time


08:00 AM


09:00 AM


09:30 AM


10:30 AM


11:00 AM


12:30 PM


01:30 PM


03:30 PM


06:00 PM


University of Oxford, UK


St Hugh's College, University of Oxford
St Margaret's Rd, Oxford OX2 6LE, UK